Tirzepatide in Las Vegas
Prescribed and monitored by a board-certified physician — labs first, honest answers, and medication at pharmacy cost with no markup. Start with an $88 evaluation.
Medically reviewed by Charles Kamen, MD, board-certified neurologist ·
Tirzepatide is a dual GIP and GLP-1 receptor agonist, FDA-approved as Zepbound® for chronic weight management and as Mounjaro® for type 2 diabetes. It is one of the most effective weight-management medications available, and also a serious prescription drug that deserves real medical supervision rather than a quick checkout form.
At LiveNow Longevity, tirzepatide therapy is run the way a physician practice should run it: an evaluation and baseline labs first, an individualized dose plan, scheduled follow-ups, and medication dispensed by a licensed US pharmacy at pass-through cost with no markup. We are a medical practice, not a medication retailer. If tirzepatide is not appropriate for you, Dr. Kamen will tell you, and what is appropriate instead.
We serve Las Vegas, Henderson, Green Valley, and all of Nevada, in person at our clinic at Eastern Avenue and the 215, or by secure telehealth. For the full picture across every GLP-1-pathway option, see our GLP-1 medication comparison and semaglutide vs. tirzepatide vs. retatrutide guide.
How Tirzepatide Therapy Works Here
$88 evaluation with board-certified neurologist Dr. Charles Kamen, MD — applied toward your plan
Baseline labs before any prescription (metabolic panel, A1C, and more as indicated)
Individualized dosing and titration — not a one-size-fits-all subscription
Medication dispensed by licensed US pharmacies at pass-through cost, no markup
Nutrition and muscle-preservation guidance built into your plan
Scheduled physician follow-ups, dose adjustments, and side-effect management
How Tirzepatide Works
Tirzepatide is a dual GIP and GLP-1 receptor agonist. GLP-1 and GIP are incretin hormones your body already releases after eating. They regulate insulin, slow stomach emptying, and signal fullness to the brain. Tirzepatide activates both receptors, which is the key difference from semaglutide (a single-pathway GLP-1 agonist). FDA-approved as Zepbound® (chronic weight management) and Mounjaro® (type 2 diabetes), it is administered as a once-weekly subcutaneous injection.
Because it affects appetite, gastric emptying, and insulin regulation, tirzepatide is a serious prescription, not something to order from a pop-up website. At our practice it is dosed by a physician, titrated to your response, and adjusted based on your labs and follow-up visits.
What the Trials Showed
Tirzepatide’s efficacy is established across two landmark NEJM trials: SURMOUNT-1 (obesity) and SURPASS-2 (a head-to-head against semaglutide in type 2 diabetes). These are trial averages from large randomized studies, not individual guarantees. Results vary widely and depend on dose response, nutrition, and activity.
| Trial | Result | Context |
|---|---|---|
| SURMOUNT-1 (obesity, no diabetes) | ~20.9% average weight loss at 72 weeks, highest studied dose | Randomized, placebo-controlled, 2,539 participants |
| SURMOUNT-1 — share losing ≥20% of body weight | ~57% of participants | At the highest studied dose vs. 3% on placebo |
| SURPASS-2 (type 2 diabetes, head-to-head vs. semaglutide) | Superior A1C reduction and greater weight loss | Randomized, 1,879 participants; open-label, 40 weeks |
For comparison, the STEP 1 trial of semaglutide reported an average of about 14.9% weight loss at 68 weeks. Individual results vary widely and are not guaranteed. Tirzepatide is a prescription medication used alongside nutrition and activity changes, not a substitute for them. See our semaglutide in Las Vegas guide for that trial in full context.
What to Expect — Week by Week
| Phase | What happens | Physician role |
|---|---|---|
| Evaluation | $88 visit + baseline labs (metabolic panel, A1C, more as indicated) | Dr. Kamen confirms tirzepatide is appropriate and sets your starting dose |
| Titration (weeks 1–8+) | Dose increased gradually to manage tolerability and side effects | Follow-up visits, side-effect management, dose adjustment |
| Target dose | Steady dose with appetite and response monitored | Ongoing labs and plan adjustments based on your results |
| Maintenance | Sustained plan with nutrition and muscle-preservation guidance | Scheduled check-ins; discontinue or change if appropriate |
Individual results vary and are not guaranteed. Tirzepatide is a prescription medication used alongside nutrition and activity changes, not a substitute for them.
Is Tirzepatide FDA-Approved?
Yes. Tirzepatide is FDA-approved as Zepbound® for chronic weight management and as Mounjaro® for type 2 diabetes — both are verifiable in the FDA drug database. Compounded versions of tirzepatide also exist, produced by licensed 503A/503B compounding pharmacies under a physician’s prescription when clinically indicated — these are not FDA-approved finished products, and are a different category from brand-name Zepbound or Mounjaro. We use FDA-approved tirzepatide when appropriate for your plan.
One medication that is not available anywhere, including Las Vegas, is retatrutide, a newer, investigational triple-receptor agonist still in Phase 3 trials. It cannot be dispensed as a standard prescription while it remains unapproved. See our retatrutide in Las Vegas guide for the current research and FDA-approval outlook.
Tirzepatide vs. Semaglutide vs. Retatrutide
| Medication | Receptor targets | FDA status | Available now? |
|---|---|---|---|
| Tirzepatide | GLP-1 + GIP | FDA-approved | Yes — after evaluation |
| Semaglutide | GLP-1 | FDA-approved | Yes — after evaluation |
| Retatrutide | GLP-1 + GIP + glucagon | Investigational (not approved) | No — ask Dr. Kamen |
How to Get Tirzepatide in Las Vegas
The honest answer starts with a physician, not a checkout page. Tirzepatide is prescription-only in Nevada, so an evaluation with Dr. Kamen (history, goals, and baseline labs) comes first. If it is clinically appropriate, it is prescribed and dispensed by a licensed US pharmacy.
Be careful of “research chemical” or gray-market vendors advertising tirzepatide online without a prescription. These products are not manufactured, tested, or labeled for human use, and we strongly recommend against them — there is no way to verify their purity, dose accuracy, or sterility outside of a licensed pharmacy. What you can do today is book an $88 evaluation — in person at our southeast Las Vegas clinic at Eastern Avenue and the 215, or by secure telehealth anywhere in Nevada.
Tirzepatide Cost in Las Vegas — Transparent Pricing
We do not sell a subscription and there is no hidden markup. You see the real numbers before you commit:
- $88 evaluation — with Dr. Kamen, applied toward your plan if you continue.
- Baseline labs — ordered as indicated; cost depends on what your panel requires and your coverage.
- Medication at pharmacy pass-through cost, no markup — billed at exactly what the licensed US pharmacy charges, based on your dose.
Your exact monthly cost is reviewed with you in person before you pay anything beyond the evaluation. If a different option — like semaglutide — fits your situation and budget better, that is what gets recommended.
Tirzepatide in Las Vegas — FAQ
How do I get tirzepatide in Las Vegas?
Tirzepatide is a prescription medication — at LiveNow Longevity, you start with an $88 medical evaluation with board-certified neurologist Dr. Charles Kamen, MD covering history, labs, and goals. If tirzepatide is clinically appropriate, it is prescribed and dispensed through a licensed US pharmacy.
How much does tirzepatide cost in Las Vegas?
At LiveNow Longevity, you start with an $88 physician evaluation that is applied toward your plan if you continue. Medication is then billed at pass-through cost with no markup; your exact monthly cost depends on dose and the pharmacy filling your prescription, and is reviewed with you in person before you commit to anything.
What is the difference between tirzepatide and semaglutide?
Tirzepatide activates both GLP-1 and GIP receptors, while semaglutide activates only the GLP-1 receptor. Which is more appropriate depends on your history, labs, tolerability, and goals — exactly what the evaluation determines. See our physician-reviewed comparison for details.
Is tirzepatide FDA-approved?
Yes — tirzepatide is FDA-approved as Zepbound® for chronic weight management and as Mounjaro® for type 2 diabetes. Whether it is appropriate for you is a medical decision made after evaluation and labs.
Do you offer telehealth for tirzepatide in Nevada?
Yes — Nevada residents can complete the evaluation and follow-ups by secure telehealth, with labs drawn at a location near you. In-person visits are available at our southeast Las Vegas clinic at Eastern Ave and the 215.
Who should not take tirzepatide?
Tirzepatide is not appropriate for everyone — people with a personal or family history of medullary thyroid carcinoma or MEN 2 are generally excluded, and it requires caution with a history of pancreatitis or certain GI conditions. This is why care starts with a physician evaluation, not a checkout cart.
How much does tirzepatide cost per month in Las Vegas?
At LiveNow Longevity the $88 evaluation is applied to your plan if you continue, and the medication itself is billed at pharmacy pass-through cost with no markup. Monthly cost depends on your dose and the dispensing pharmacy, and is reviewed with you in person before you commit — you see the real number before paying, never a hidden subscription.
How fast does tirzepatide work, and what results can I expect?
Tirzepatide is titrated up gradually over weeks to manage tolerability. Appetite changes often come early; measurable weight change typically builds over the first few months at the target dose. In the SURMOUNT-1 trial, participants at the highest studied dose averaged about 20.9% weight loss at 72 weeks. That is a trial average, not an individual promise — results vary widely and depend on dose response, nutrition, and activity, and your plan is adjusted based on your actual response.
What are the most common side effects of tirzepatide?
The most common tirzepatide side effects are gastrointestinal — nausea, delayed stomach emptying, and appetite suppression — which is exactly why dose is titrated slowly and monitored by a physician. Rarer but serious effects are discussed during your evaluation. Side-effect management is built into your follow-up visits, not left to a chat box.
Is compounded tirzepatide the same as Mounjaro or Zepbound?
No — FDA-approved Mounjaro and Zepbound are manufactured by Eli Lilly, while compounded tirzepatide is produced by licensed 503A/503B compounding pharmacies under a physician prescription and is not FDA-approved. We use FDA-approved tirzepatide when appropriate. See our full physician-reviewed breakdown of compounded vs brand tirzepatide.
Tirzepatide or semaglutide — which is right for me?
Both are FDA-approved GLP-1-pathway medications; tirzepatide also activates the GIP receptor. Which fits you depends on your history, tolerability, and goals — decided after evaluation, not from a chart. Read our physician-reviewed tirzepatide vs semaglutide comparison for the details.
Should I choose tirzepatide over retatrutide?
Retatrutide is not an option right now — it remains investigational and is not FDA-approved, so no clinic can prescribe it. Tirzepatide is FDA-approved and available today after an evaluation. If you are curious where retatrutide stands, Dr. Kamen can walk you through the current research at your visit; see our retatrutide in Las Vegas guide for the full picture.
How do I know if I qualify for tirzepatide?
Eligibility is determined at your evaluation — Dr. Kamen reviews your BMI, medical history, current medications, and baseline labs to decide whether tirzepatide is an appropriate and safe option for you, or whether another approach fits better. There is no way to know for certain without that visit.
What happens at the first tirzepatide appointment?
Your first visit is the $88 evaluation: a full history and goals discussion with Dr. Kamen, a physical assessment, and baseline labs ordered as indicated. If tirzepatide is appropriate, your starting dose and monitoring plan are set at that same visit — there is no separate "consultation fee" layered on top.
Selected Research
- Jastreboff AM, et al. N Engl J Med. 2022;387(3):205-216. (SURMOUNT-1: Tirzepatide Once Weekly for the Treatment of Obesity).
- Frías JP, et al. N Engl J Med. 2021;385(6):503-515. (SURPASS-2: Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes).
- Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002. (STEP 1: Once-Weekly Semaglutide in Adults with Overweight or Obesity).
- Lincoff AM, et al. N Engl J Med. 2023;389(24):2221-2232. (SELECT: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes).
Trial-result sources only. Not a treatment claim or a guarantee. Individual results vary, and appropriateness is determined by a licensed physician after evaluation.
Physician-Led in Las Vegas
Find out if tirzepatide is right for you
Schedule the $88 evaluation. After your labs and review, Dr. Kamen discusses an individualized plan and its costs — including whether semaglutide or another approach fits you better. See also our physician-reviewed comparison.
Ready to start your longevity care?
Book your $88 evaluation with Dr. Kamen today, online, by phone, or by text.
Prefer to talk? Call (702) 808-2650 or text us to book.
Also serving Henderson — or explore semaglutide weight loss in Las Vegas.